NCT03980184View on ClinicalTrials.gov

Guanfacine to Improve Substance Use Outcomes in Women

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2019

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Substance Use Disorders
Interventions
DRUG

Guanfacine

Guanfacine 3mg/day Versus Placebo

OTHER

Behavioral Counseling

placebo

Trial Locations (1)

06519

The Yale Stress Center: Yale University, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT03980184 - Guanfacine to Improve Substance Use Outcomes in Women | Biotech Hunter | Biotech Hunter